NDRG2 and central nervous system cancer: Tepel and colleagues [84] observed decreased NDRG2 protein and mRNA expression in grade IV gliomas compared with grade II and grade III gliomas (n = 67) and observed hypermethylation in 62% of grade IV gliomas (n = 34).